유도 만능 줄기세포(iPS 세포) 생산 시장 : 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global induced pluripotent stem cells production market size is expected to reach USD 5.31 Billion in 2034 from USD 2.23 Billion in 2025, growing at a CAGR of 10.11 during 2026-2034.The Global Induced Pluripotent Stem Cells (iPSCs) Production Market is witnessing strong growth due to rising interest in regenerative medicine and cell-based therapies. iPSCs are adult cells that are reprogrammed to an embryonic-like state, allowing them to differentiate into various cell types. This technology offers significant potential in disease modeling, drug screening, and tissue regeneration. Increasing research activities in stem cell biology and the growing prevalence of chronic diseases are driving the market forward.

A major driver for this market is the expanding application of iPSCs in personalized medicine and advanced therapeutic development. Pharmaceutical companies are using iPSCs to test drug toxicity and efficacy, reducing the risk of failure in later clinical stages. Supportive government regulations, funding programs, and partnerships between research institutes and biotech firms are also accelerating production capabilities. Technological improvements in reprogramming methods have made the process more efficient and cost-effective.

Looking ahead, the market is expected to grow rapidly with increasing clinical trials involving stem cell therapies. The development of automated production systems and standardized protocols will further enhance scalability. Asia-Pacific is emerging as a strong region due to expanding biotechnology infrastructure. As regenerative medicine becomes more mainstream, the iPSCs production market is likely to see sustained long-term growth and innovation.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Process

• Manual iPSC Production Process
• Automated iPSC Production Process

By Workflow

• Reprogramming
• Cell Culture
• Cell Characterization/Analysis
• Engineering
• Others

By Product

• Instruments/Devices
• Automated Platforms
• Consumables & Kits
• Services

By Application

• Drug Development & Discovery
• Regenerative Medicine
• Toxicology Studies
• Others

By End Use

• Research & Academic Institutes
• Biotechnology & Pharmaceutical Companies
• Hospitals & Clinics

COMPANIES PROFILED

• Lonza, Axol Bioscience Ltd., Evotec, Hitachi Ltd., Reprocell Inc., Merck KGaA, Reprocells Inc., Fate Therapeutics, Thermo Fisher Scientific Inc., StemCellsFactory III, Applied StemCells Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET: BY PROCESS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Process
• 4.2. Manual iPSC Production Process Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Automated iPSC Production Process Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Workflow
• 5.2. Reprogramming Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cell Culture Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cell Characterization/Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Engineering Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET: BY PRODUCT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Product
• 6.2. Instruments/Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Automated Platforms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Consumables & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Drug Development & Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Toxicology Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET: BY END USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End Use
• 8.2. Research & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Biotechnology & Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Process
  • 9.2.2 By Workflow
  • 9.2.3 By Product
  • 9.2.4 By Application
  • 9.2.5 By End Use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Process
  • 9.3.2 By Workflow
  • 9.3.3 By Product
  • 9.3.4 By Application
  • 9.3.5 By End Use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Process
  • 9.4.2 By Workflow
  • 9.4.3 By Product
  • 9.4.4 By Application
  • 9.4.5 By End Use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Process
  • 9.5.2 By Workflow
  • 9.5.3 By Product
  • 9.5.4 By Application
  • 9.5.5 By End Use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Process
  • 9.6.2 By Workflow
  • 9.6.3 By Product
  • 9.6.4 By Application
  • 9.6.5 By End Use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Lonza
  • 11.2.2 Axol Bioscience Ltd
  • 11.2.3 Evotec
  • 11.2.4 Hitachi Ltd
  • 11.2.5 Reprocell Inc
  • 11.2.6 Merck KGaA
  • 11.2.7 Reprocells Inc
  • 11.2.8 Fate Therapeutics
  • 11.2.9 Thermo Fisher Scientific Inc
  • 11.2.10 StemCellsFactory III
  • 11.2.11 Applied StemCells Inc